<table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<col width="1px"></col>
<col width="1px"></col>
<tbody>
<tr>
<td colspan="2" stylecode="     Toprule         Lrule          Rrule     "> Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (<linkhtml href="#LINK_7ee065f9-b0c8-4a3f-9fb7-6e9a95c45e3c">2.6</linkhtml>, <linkhtml href="#LINK_3d202171-3003-481c-9bae-b822942f1f51">5.1</linkhtml>, <linkhtml href="#LINK_ca7e95f9-76a3-4973-8c76-9ef48ddb1ac5">7</linkhtml>, <linkhtml href="#LINK_0744d443-1482-4596-b9ca-94249df7b060">12.3</linkhtml>)</td>
</tr>
<tr>
<td stylecode="    Lrule     "> Interacting Agents</td>
<td stylecode="     Rrule     ">Prescribing <br/>Recommendations</td>
</tr>
<tr>
<td stylecode="    Lrule     "> Cyclosporine, HIV protease inhibitors (tipranavir plus ritonavir), hepatitis C protease inhibitor (telaprevir) </td>
<td stylecode="     Rrule     "> Avoid atorvastatin</td>
</tr>
<tr>
<td stylecode="    Lrule     " valign="top"> HIV protease inhibitor (lopinavir plus ritonavir)</td>
<td stylecode="     Rrule     ">Use with caution and<br/>lowest dose <br/>necessary</td>
</tr>
<tr>
<td stylecode="    Lrule     "> Clarithromycin, itraconazole, HIV protease inhibitors (saquinavir plus ritonavir, darunavir plus ritonavir, fosamprenavir, fosamprenavir plus ritonavir)<br/>
<br/>
</td>
<td stylecode="     Rrule     " valign="top">
<paragraph>Do not exceed 20 <br/>mg atorvastatin <br/>daily</paragraph>
</td>
</tr>
<tr>
<td stylecode="     Botrule         Lrule     " valign="top"> HIV protease inhibitor (nelfinavir)<br/> Hepatitis C protease inhibitor (boceprevir)<br/>
<br/>
</td>
<td stylecode="     Botrule          Rrule     ">
<paragraph>Do not exceed 40 <br/>mg atorvastatin <br/>daily</paragraph>
</td>
</tr>
</tbody>
</table>